Gene: SFT2D2
Official Full Name: SFT2 domain containing 2provided by HGNC
Gene Summary: Predicted to be involved in protein transport and vesicle-mediated transport. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14180 | SFT2D2 Knockout cell line (HeLa) | Human | SFT2D2 | 1:3~1:6 | Negative | Online Inquiry |
KO14181 | SFT2D2 Knockout cell line (HCT 116) | Human | SFT2D2 | 1:2~1:4 | Negative | Online Inquiry |
KO14182 | SFT2D2 Knockout cell line (HEK293) | Human | SFT2D2 | 1:3~1:6 | Negative | Online Inquiry |
KO14183 | SFT2D2 Knockout cell line (A549) | Human | SFT2D2 | 1:3~1:4 | Negative | Online Inquiry |
SFT2D2 Gene Knockout Cell Lines are specifically designed cellular models that facilitate the study of the SFT2D2 gene, known to play a pivotal role in lipid transport and membrane dynamics. These knockout cell lines have been genetically altered to disrupt the SFT2D2 gene, resulting in the absence of its corresponding protein product. This innovative tool enables researchers to investigate the biological functions and molecular pathways associated with SFT2D2 by providing a clear comparison between normal and deficient cellular environments.
The primary mechanism of action of SFT2D2 involves its role in the transport of phospholipids within the cell, crucial for maintaining cellular membrane integrity and function. By utilizing knockout cell lines, researchers can delve into how the absence of this gene influences lipid metabolism, vesicle trafficking, and overall cellular homeostasis. This understanding is essential not only for basic biological research but also for elucidating the pathophysiology behind diseases where lipid dysregulation is a factor, such as metabolic disorders and neurological conditions.
The scientific importance of SFT2D2 Gene Knockout Cell Lines cannot be overstated. These models serve as invaluable tools in drug discovery, allowing for the identification of novel therapeutic targets and the evaluation of potential pharmacological compounds in a controlled setting. By employing these knockout models, researchers can effectively study gene function, genotype-phenotype correlations, and the impact of potential interventions in a more precise manner.
Compared to conventional cell lines, the SFT2D2 Gene Knockout variants provide a specific advantage by allowing straightforward observation of the functional knockdown effects without the confounding variables usually encountered in other models. This specificity enhances the reliability of experimental results and paves the way for more targeted therapeutic strategies.
For researchers and clinicians seeking to unravel the complexities of lipid transport and membrane biology, SFT2D2 Gene Knockout Cell Lines offer a robust and effective medium for exploration. Our company prides itself on a commitment to providing high-quality, genetically engineered cell lines supported by extensive scientific expertise, ensuring that our products stand out in facilitating groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.